Related content

Successful Treatment of Mucous Membrane Pemphigoid with the Anti-CD-20 Antibody Rituximab

By Schumann Tamara   Schmidt Enno   Booken Nina   Goerdt Sergij   Goebeler Matthias  

Acta Dermato-Venereologica, Vol. 89, Iss. 1, 2009-01 ,pp. : 101-102

Medical Journals Limited

Access to resources Recommend Favorite

Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): Five cases

By Antonucci Angela   Negosanti Massimino   Tabanelli Michela   Varotti Claudio  

Journal of Dermatological Treatment, Vol. 18, Iss. 3, 2007-01 ,pp. : 178-183

Informa Healthcare

Access to resources Recommend Favorite

Systemic Therapy of Primary Cutaneous B-cell Lymphoma, Marginal Zone Type, with Rituximab, a Chimeric Anti-CD20 Monoclonal Antibody

By Soda R.   Costanzo A.   Cantonetti M.   Orlandi A.   Bianchi L.   Chimenti S.  

Acta Dermato-Venereologica, Vol. 81, Iss. 3, 2001-06 ,pp. : 207-208

Medical Journals Limited

Access to resources Recommend Favorite

Citrobacter koseri Cellulitis During Anti-CD20 Monoclonal Antibody (Ofatumumab) Treatment for B-cell Chronic Lymphocytic Leukaemia

By Kluger Nicolas   Cartron Guillaume   Bessis Didier   Guillot Bernard   Girard Céline  

Acta Dermato-Venereologica, Vol. 90, Iss. 1, 2010-01 ,pp. : 99-100

Medical Journals Limited

Access to resources Recommend Favorite

Topische Cannabinoidagonisten: Eine effektive, neue Möglichkeit zur Behandlung von chronischem Pruritus

By Ständer S.   Reinhardt H.   Luger T.  

Der Hautarzt, Vol. 57, Iss. 9, 2006-09 ,pp. : 801-807

Springer Publishing Company

Access to resources Recommend Favorite